Canexis Pharma has received an extended GMP manufacturing license (Part I) from Swissmedic for the production of bulk finished medicinal products. This means that Canexis is now able to produce not only active ingredients such as...
Canexis Pharma AG (“Canexis”), an up-and-coming Swiss company in the field of pharmaceutical cannabis products, has received the manufacturing and narcotics license for cannabis products from Swissmedic…
We were proud to publish an article in the specialist magazine “Swiss Pharma”, issue 1/22. The topic of this issue was modern qualification with best practice examples. You will find and…